| scholarly article | Q13442814 |
| P50 | author | Kari Alitalo | Q6370341 |
| P2093 | author name string | T Karpanen | |
| P2860 | cites work | LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan | Q22008808 |
| Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
| Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 | Q24291630 | ||
| Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) | Q24321792 | ||
| A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases | Q24336293 | ||
| Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors | Q73254738 | ||
| Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer | Q73585510 | ||
| The lymphatic endothelium of the avian wing is of somitic origin | Q73603919 | ||
| Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma | Q73937580 | ||
| Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma | Q73943280 | ||
| N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling | Q74122026 | ||
| Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer | Q78074820 | ||
| Proteolytic processing regulates receptor specificity and activity of VEGF-C | Q24532314 | ||
| Openings between defective endothelial cells explain tumor vessel leakiness | Q24681507 | ||
| Angiogenesis in cancer and other diseases | Q27861015 | ||
| Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
| VEGF-D promotes the metastatic spread of tumor cells via the lymphatics | Q28200072 | ||
| Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis | Q28200101 | ||
| Hyperplasia of lymphatic vessels in VEGF-C transgenic mice | Q28238886 | ||
| VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane | Q28245526 | ||
| Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C | Q28266440 | ||
| Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium | Q28506923 | ||
| Targeting tumor vasculature with homing peptides from phage display | Q30979146 | ||
| Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis | Q33927967 | ||
| Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages | Q34091556 | ||
| Lymphangiogenesis and tumor metastasis: myth or reality? | Q34215567 | ||
| Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium | Q34502407 | ||
| Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma | Q35746804 | ||
| Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human Tumors | Q35753219 | ||
| VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer | Q35786920 | ||
| Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features | Q35787996 | ||
| Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood | Q35851436 | ||
| VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. | Q36641154 | ||
| Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues | Q36642309 | ||
| Vascular endothelial growth factor C induces angiogenesis in vivo. | Q36734917 | ||
| Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice | Q39714957 | ||
| Circulating endothelial precursors: mystery, reality, and promise | Q40741679 | ||
| Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. | Q40827632 | ||
| Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis | Q42280089 | ||
| Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia | Q42800633 | ||
| In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. | Q42833515 | ||
| Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. | Q42839298 | ||
| Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia | Q42850939 | ||
| Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy | Q44240071 | ||
| Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. | Q52539892 | ||
| Chemotherapy targeted to tumor vasculature. | Q54116633 | ||
| Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. | Q55261166 | ||
| Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth | Q56825474 | ||
| Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis | Q57382204 | ||
| VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues | Q57382249 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | enzyme | Q8047 |
| cancer | Q12078 | ||
| peptide | Q172847 | ||
| membrane protein | Q423042 | ||
| lymphatic system | Q712604 | ||
| growth factor receptor | Q118226 | ||
| neoplasm | Q1216998 | ||
| cell surface receptor | Q2476074 | ||
| hemic and immune systems | Q70202933 | ||
| P304 | page(s) | F37-42 | |
| P577 | publication date | 2001-09-01 | |
| 2001-09-17 | |||
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Lymphatic vessels as targets of tumor therapy? | |
| P478 | volume | 194 |
| Q59694186 | Angiogenesis and melanoma |
| Q36305548 | Blood and lymph vessels in embryonic tumors |
| Q38839716 | Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma |
| Q39681568 | Cold shock domain protein A (CSDA) overexpression inhibits tumor growth and lymph node metastasis in a mouse model of squamous cell carcinoma |
| Q39324791 | Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma |
| Q39315570 | Development of a tridimensional microvascularized human skin substitute to study melanoma biology |
| Q52726355 | Effect of High VEGF-C mRNA Expression on Achievement of Complete Remission in Adult Acute Myeloid Leukemia |
| Q31154386 | Effect of vascular endothelial growth factor C (VEGF-C) gene transfer in rat model of secondary lymphedema |
| Q81502581 | Effect of vascular endothelial growth factor C (VEGF-C) gene transfer in rat model of secondary lymphedema |
| Q37719337 | Gastrointestinal cancer metastasis and lymphatic advancement |
| Q44433450 | HMGB1 combining with tumor-associated macrophages enhanced lymphangiogenesis in human epithelial ovarian cancer |
| Q83991629 | Inflammatory lymphangiogenesis in a rat transplant model of interstitial fibrosis and tubular atrophy |
| Q35587730 | Lack of lymphangiogenesis during breast carcinogenesis |
| Q80827541 | Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix |
| Q26773022 | Lymphangiogenesis and Lesion Heterogeneity in Interstitial Lung Diseases |
| Q34770288 | Lymphangiogenesis and cancer metastasis |
| Q38190359 | Lymphangiogenesis and lymphatic vessel remodelling in cancer |
| Q47744569 | Lymphangiogenesis guidance by paracrine and pericellular factors |
| Q24305315 | Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor |
| Q79787099 | Lymphatic microvessel density as prognostic marker in colorectal cancer |
| Q89866258 | Meningeal lymphatic vessels regulate brain tumor drainage and immunity |
| Q34710547 | Molecular mechanisms of lymphangiogenesis in health and disease |
| Q33977081 | Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects |
| Q38217530 | Novel targeted therapies for the treatment of penile cancer |
| Q44548329 | Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity |
| Q30479201 | Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades |
| Q35928217 | Radiogenic lymphangiogenesis in the skin |
| Q47427416 | Self-assembly of peptide amphiphiles for drug delivery: the role of peptide primary and secondary structures. |
| Q37354128 | The VEGF signaling pathway in cancer: the road ahead |
| Q87600987 | The abnormal expressions of tristetraprolin and the VEGF family in uraemic rats with peritoneal dialysis |
| Q54646523 | The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma |
| Q36600928 | The history of the angiogenic switch concept |
| Q36609889 | The role of the VEGF-C/VEGFR-3 axis in cancer progression |
| Q35866159 | Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years). |
| Q91789424 | Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis |
| Q24669710 | Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis |
| Q64064605 | Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3 |
| Q35187933 | Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. |
| Q80352869 | [Micro-metastases and non-small cell lung cancer] |
Search more.